| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |